ResearcherHuazhong University of Science and TechnologyActive in the last 2 years
Xin Long
Matched on ORCID iD 0009-0009-6746-5500; OpenAlex author ID A5046304240. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 5
- Disruption of iron homeostasis sensitizes pancreatic cancer to irreversible electroporation. Co-author DOI 10.1038/s41467-026-68585-z↗
- Co-inhibition of RAGE and TLR4 sensitizes pancreatic cancer to irreversible electroporation in mice by disrupting autophagy. Co-author DOI 10.1038/s41401-025-01487-w↗
- Irreversible Electroporation-Induced Inflammation Facilitates Neutrophil-Mediated Drug Delivery to Enhance Pancreatic Cancer Therapy. Last author DOI 10.1021/acs.molpharmaceut.4c00006↗
- Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible Electroporation. Co-author DOI 10.1021/acsnano.3c05009↗
- Local Release of TGF-β Inhibitor Modulates Tumor-Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Im… Co-author DOI 10.1002/advs.202105240↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jun Zhao · 5 shared papers, 2022–2026 · strength 1.12
- Paper Disruption of iron homeostasis sensitizes pancreatic cancer to irreversible electroporation. DOI 10.1038/s41467-026-68585-z↗
- Paper Co-inhibition of RAGE and TLR4 sensitizes pancreatic cancer to irreversible electroporation in mice by disrupting autop… DOI 10.1038/s41401-025-01487-w↗
- Paper Irreversible Electroporation-Induced Inflammation Facilitates Neutrophil-Mediated Drug Delivery to Enhance Pancreatic C… DOI 10.1021/acs.molpharmaceut.4c00006↗
- Teng Huang · 3 shared papers, 2022–2024 · strength 0.56
- Paper Irreversible Electroporation-Induced Inflammation Facilitates Neutrophil-Mediated Drug Delivery to Enhance Pancreatic C… DOI 10.1021/acs.molpharmaceut.4c00006↗
- Paper Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible Ele… DOI 10.1021/acsnano.3c05009↗
- Paper Local Release of TGF-β Inhibitor Modulates Tumor-Associated Neutrophils and Enhances Pancreatic Cancer Response to Comb… DOI 10.1002/advs.202105240↗
- Tianan Jiang · 2 shared papers, 2023–2025 · strength 0.43
- Paper Co-inhibition of RAGE and TLR4 sensitizes pancreatic cancer to irreversible electroporation in mice by disrupting autop… DOI 10.1038/s41401-025-01487-w↗
- Paper Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible Ele… DOI 10.1021/acsnano.3c05009↗
- Linrong Li · 1 shared paper, 2026 · strength 0.30
- Tao Yin · 1 shared paper, 2026 · strength 0.30
- Hui Xu · 2 shared papers, 2022–2023 · strength 0.30
- Paper Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible Ele… DOI 10.1021/acsnano.3c05009↗
- Paper Local Release of TGF-β Inhibitor Modulates Tumor-Associated Neutrophils and Enhances Pancreatic Cancer Response to Comb… DOI 10.1002/advs.202105240↗
- Chun Li · 2 shared papers, 2022–2023 · strength 0.30
- Paper Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible Ele… DOI 10.1021/acsnano.3c05009↗
- Paper Local Release of TGF-β Inhibitor Modulates Tumor-Associated Neutrophils and Enhances Pancreatic Cancer Response to Comb… DOI 10.1002/advs.202105240↗
- Cuifang Ye · 1 shared paper, 2025 · strength 0.27
- Tao Yin · 1 shared paper, 2023 · strength 0.16
- Jian Shen · 1 shared paper, 2022 · strength 0.14
- Huiming Peng · 1 shared paper, 2022 · strength 0.14
- Heshui Wu · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.